VACCINE INNOVATION IN PUBLIC HEALTH: CHALLENGES AND OPPORTUNITIES IN DEVELOPING NATIONS

Main Article Content

Dr Ashwini L H
Dr Vinaykumar L H
Dr Hanumanaik L

Keywords

Vaccine innovation, public health, developing nations, vaccine hesitancy, educational interventions, socio-cultural factors

Abstract

Vaccine innovation is essential for improving public health outcomes, particularly in developing nations where access and acceptance vary significantly. This study aims to investigate regional disparities in vaccine accessibility, acceptance, and underlying socio-cultural factors across Sub-Saharan Africa, Southeast Asia, and Latin America, highlighting the challenges and opportunities in these regions. A cross-sectional study design was employed to analyze vaccine access and acceptance levels among populations in these three regions. Data were collected using surveys targeting key demographics and socio-economic indicators, including education level and cultural beliefs. Statistical analyses assessed the correlation between these factors and vaccine uptake rates. Findings reveal notable differences across regions, with Latin America showing higher rates of vaccine accessibility and acceptance due to stronger health infrastructure and education initiatives. In Southeast Asia, cultural beliefs and mistrust in healthcare systems contribute to higher vaccine hesitancy. Educational level was positively correlated with vaccine access across all regions, suggesting that educational interventions may improve vaccination rates. The study underscores the importance of region-specific strategies to enhance vaccine acceptance and accessibility in developing nations. Educational programs and culturally sensitive outreach efforts are crucial for addressing vaccine hesitancy. Future research should focus on longitudinal studies and experimental designs to establish causality and evaluate intervention efficacy, ultimately supporting more tailored public health strategies.

Abstract 57 | pdf Downloads 31

References

1. Kumraj G, Pathak S, Shah S, Majumder P, Jain J, Bhati D, Hanif S, Mukherjee S, Ahmed S. Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward. Hum Vaccin Immunother. 2022 Dec 31;18(1):2020529. doi: 10.1080/21645515.2021.2020529. Epub 2022 Jan 27. PMID: 35086416; PMCID: PMC8986212.
2. Moyazzem Hossain M, Abdulla F, Rahman A. Challenges and difficulties faced in low- and middle-income countries during COVID-19. Health Policy Open. 2022 Dec;3:100082. doi 10.1016/j.hpopen.2022.100082. Epub 2022 Nov 8. PMID: 36405972; PMCID: PMC9642028.
3. Tozzi AE, Gesualdo F, D'Ambrosio A, Pandolfi E, Agricola E, Lopalco P. Can Digital Tools Be Used for Improving Immunization Programs? Front Public Health. 2016 Mar 8;4:36. doi: 10.3389/fpubh.2016.00036. PMID: 27014673; PMCID: PMC4782280.
4. Gavi, the Vaccine Alliance. (2019). Public-private partnerships for immunization programs: A review. Global Vaccine Report, 10(2), 55-64.
5. Galagali PM, Kinikar AA, Kumar VS. Vaccine Hesitancy: Obstacles and Challenges. Curr Pediatr Rep. 2022;10(4):241-248. doi: 10.1007/s40124-022-00278-9. Epub 2022 Oct 8. PMID: 36245801; PMCID: PMC9546747.
6. Ghattas M, Dwivedi G, Lavertu M, Alameh MG. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines (Basel). 2021 Dec 16;9(12):1490. doi: 10.3390/vaccines9121490. PMID: 34960236; PMCID: PMC8708925.
7. Feikin DR, Flannery B, Hamel MJ, Stack M, Hansen PM. Vaccines for Children in Low- and Middle-Income Countries. In: Black RE, Laxminarayan R, Temmerman M, Walker N, eds. Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; April 5, 2016.
8. Plotkin, S., Orenstein, W., & Offit, P. (2017). Vaccines (7th ed.). Elsevier.
9. Sallam, M. (2021). Vaccine hesitancy in developing nations: A systematic review. BMC Public Health, 21(1), 1-10.
10. WHO. (2021). Vaccination coverage and access in low-income regions. Global Health Report, 34(1), 45-53.
11. Dubé, E., Laberge, C., Guay, M., Bramadat, P., Roy, R., & Bettinger, J. A. (2015). Vaccine hesitancy: An overview. Human Vaccines & Immunotherapeutics, 9(8), 1763-1773.
12. Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Stack, M. L., Sinha, A., & Mirelman, A. (2016). Return on investment from childhood immunization in low- and middle-income countries, 2011-20. Health Affairs, 35(2), 199-207.
13. Schwartz JL, Caplan AL. Ethics of vaccination programs. Curr Opin Virol. 2011;1(4):263-267. doi:10.1016/j.coviro.2011.05.009

Most read articles by the same author(s)

1 2 > >>